Facebook  Twitter  Youtube  ISSUU  RSS  Email

Media Contacts

UK
Dominic Kavakeb
dominic.kavakeb@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Twitter

TransparencyUK RT @MaggieMrphy: So we agree corruption is a UK issue, so why are all the deadlines slipping? Recommended read from @rose_zussman https://…
11mreplyretweetfavorite
TransparencyUK As we leave the EU, we can’t leave our defences against corruption behind! @rose_zussman writes in @raconteur https://t.co/vrtt9D9ZGo
2hreplyretweetfavorite
TransparencyUK RT @duncanhames: New @bellingcat analysis finds SLPs (UK's home-grown secrecy vehicle) used by more people in Russia+Ukraine than UK. https…

Tag Cloud

Allegations anti-bribery anti-corruption summit anti money laundering bribery BSkyB Cabinet Office Chart companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office illicit enrichment intern journalists Letter Leveson Inquiry London Merkel money laundering offshore tax open governance pharmaceuticals PHP Prime Minister Register of Interests Research Resources Social Accountability statement Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Stay Informed

Sign up for updates on TI-UK's work & corruption news from around the globe.

Can Data Help Us Attain Healthier Lives

Written by Guest on Wednesday, 1 June 2016

The global pharmaceutical sector is highly vulnerable to corruption abuse, with both governments and companies needing to properly address the corruption risks. In this mini-blog series two insights of corruption in the health systems, which the pharmaceutical sector is a dominant area of, are given. Both of insights come from Nigeria, a country that demonstrated strong leadership at the recent International Anti-Corruption Summit in London.  Corruption in the pharmaceutical sector is not only present in Nigeria, but in all countries, and due to the transnational nature of the pharmaceutical sector issues that manifest themselves in one country such as Nigeria often have roots in another area such as Europe.

Some months ago, Abigail went into labour after midnight. With no motorable access road or vehicle to transport her to the General hospital in town, Abigail’s situation became desperate. Unfortunately, the newly constructed Primary health care centre (PHC) right beside their home was of no use even though by its structure, it is a “Type-2” PHC which from the minimum standards for primary health care, ought to provide childbirth support and services.

Procurement Monitors tell a part of the story. The poorer you are, the further away you are from health care access. The scale and gravity of the issue is brought to light by the Human development statistics which reveal that  50.9% of Nigerians are multi-dimensionally poor and by inference, further away from health care access. To enable increased access to health care, every year, the Nigerian Government allocates a budgetary amount to the construction of primary health care centres (PHCs).  A breakdown of eventual amounts provided for the construction of Primary health care centers by one of the health agencies is as follows:

Picture1

Experiences such as Abigail’s however, question the effectiveness of the procurement processes for increased health care access. To understand the results that follow allocations for primary health care, procurement monitors followed the data trail. It however, became difficult to link the data on budget estimates with the data on eventual sums for contracts awarded, and even more difficult to identify the exact locations for each of the constructed primary health care centres. To address this challenge, we tried to standardize our data using the Open Contracting data standards. This was carried out using our locally developed platform, Budeshi. It is in linking budget and procurement data together that we discovered the community where Abigail leaves, the existence of a completed PHC there and its non-functionality.

Picture2

Stories of non-functional primary health care services are rife in Nigeria and teach us that it is never enough to see a projection marked as completed on paper. While Abigail survived the ordeal of being transported on a motorcycle in the dead of the night to the General hospital, we must not take for granted the fact that certain people are used to certain hardships. To do so would also be to accept the high rate of maternal mortality; most of which is underreported in the poorest parts of Nigeria and across sub-saharan Africa. Rather we need to use data to help trace the impact of deployed infrastructure and expose areas of corruption, inefficiencies and weaknesses in public service delivery. Linked data as exemplified by the OCDS and implemented by Budeshi can help us make sense of public sector processes that affect our life’s quality.

The National Primary Health Care Development Agency and the Nigerian Parliament have been informed of this non-functional primary health care centre. The senate has responded to the effect that an investigation is ongoing.

Seember Nyager is an Open Knowledge/Code4Africa Open Government Fellow advocating for the adoption of open contracting data standards in Nigeria. This is a short adaptation from the article “Can Data help us attain healthier lives?” Budeshi is a platform that links procurement and Budget data to public services using the Open contracting data standards and Seember curates the work of procurement monitors in Nigeria on www.blog.budeshi.org. Follow the work of procurement monitors on Twitter @ppmonitorNG.Photo: Flickr / Alex Proimos.

On Thursday 2 June TI will  be releasing research identifying key challenges and solutions to preventing corruption in the pharmaceutical sector. ‘Corruption in the pharmaceutical sector: diagnosing the challenges’ has been produced by TI’s Pharmaceuticals & Healthcare Programme, a new global initiative based in Transparency International UK.

104

Read 104 times Last modified on Wednesday, 01 June 2016 13:09

Guest

The TI-UK blog features thought and opinion from guest writers as well as TI staff. Any opinions expressed by external contributors do not necessarily reflect the views of Transparency International UK.

Leave a Reply

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of